Labetalol |
Trandate |
Normozide |
Normodyne |
C29146 |
SPECTRUM_001607 |
NCGC00089800-02 |
PRESTWICK3_000277 |
C07063 |
SPECTRUM5_001010 |
3869 |
KBIOGR_000727 |
LABETALOLUM |
LABETALOLUM [INN-LATIN] |
PRESTWICK1_000277 |
KBIO2_002087 |
AB00053659 |
LABETOLOL |
IDI1_000474 |
DB00598 |
2-HYDROXY-5-{1-HYDROXY-2-[(1-METHYL-3-PHENYLPROPYL)AMINO]ETHYL}BENZAMIDE |
KBIO2_004655 |
2-HYDROXY-5-[1-HYDROXY-2-(4-PHENYLBUTAN-2-YLAMINO)ETHYL]BENZAMIDE |
AC-18747 |
BENZAMIDE, 2-HYDROXY-5-[1-HYDROXY-2-[(1-METHYL-3-PHENYLPROPYL)AMINO]ETHYL]- |
BPBIO1_000170 |
3-CARBOXAMIDO-4-HYDROXY-ALPHA-((1-METHYL-3-PHENYLPROPYLAMINO)METHYL)BENZYL ALCOHOL |
D08106 |
LABETALOL (INN) |
BSPBIO_000154 |
IBIDOMIDE |
PRESTWICK2_000277 |
EINECS 253-258-3 |
SPECTRUM4_000184 |
BSPBIO_003142 |
KBIO3_002642 |
CID3869 |
KBIO2_007223 |
9275 |
UNII-R5H8897N95 |
NINDS_000474 |
MOLPORT-003-898-140 |
CHEBI:6343 |
TL8002725 |
KBIOSS_002087 |
NCGC00015595-06 |
SCH-19927 |
HSDB 6537 |
BRD-A07440155-003-05-6 |
2-HYDROXY-5-(1-HYDROXY-2-((1-METHYL-3-PHENYLPROPYL)AMINO)ETHYL)BENZAMIDE |
AH-5158 |
SPECTRUM3_001581 |
SPECTRUM2_000863 |
BENZAMIDE, 2-HYDROXY-5-(1-HYDROXY-2-((1-METHYL-3-PHENYLPROPYL)AMINO)ETHYL)- |
DAP000038 |
LABETALOL [INN:BAN] |
5-(1-HYDROXY-2-(1-METHYL-3-PHENYLPROPYLAMINO)ETHYL)SALICYLAMIDE |
36894-69-6 |
PRESTWICK0_000277 |
AC1L1GW8 |
SBB067266 |
LOPAC0_000687 |
AH 5158 |
KBIO1_000474 |
L001344 |
SPBIO_002373 |
ALBETOL |
DIVK1C_000474 |
LS-26936 |
SPBIO_000905 |
BENZAMIDE,2-HYDROXY-5-[(1R)-1-HYDROXY-2-[[(1S)-1-METHYL-3-PHENYLPROPYL]AMINO]ETHYL]-,REL- |
3-CARBOXAMIDO-4-HYDROXY-.ALPHA.-((1-METHYL-3-PHENYLPROPYLAMINO)METHYL)BENZYL ALCOHOL |
2-HYDROXY-5-{1-HYDROXY-2-[(4-PHENYLBUTAN-2-YL)AMINO]ETHYL}BENZENE-1-CARBOXIMIDIC ACID |
Q-201273 |
FT-0630598 |
KB-230863 |
U685 |
OR333390 |
OR263607 |
OR067997 |
BC214322 |
AK116436 |
NCGC00015595-07 |
NCGC00015595-04 |
NCGC00015595-03 |
R5H8897N95 |
MCULE-6427232261 |
CCG-204772 |
AKOS015908406 |
83167-32-2 |
83167-24-2 |
LABETALOL HYDROCHLORIDE (SALT/MIX) |
SGUAFYQXFOLMHL-UHFFFAOYSA-N |
2-HYDROXY-5-[(1S)-1-HYDROXY-2-{[(2S)-4-PHENYLBUTAN-2-YL]AMINO}ETHYL]BENZAMIDE |
BDBM25758 |
GTPL7207 |
SCHEMBL4582 |
NORMODYNE (SALT/MIX) |
TRANDATE (SALT/MIX) |
AMIPRESS (SALT/MIX) |
2-HYDROXY-5-{1-HYDROXY-2-[(4-PHENYLBUTAN-2-YL)AMINO]ETHYL}BENZAMIDE |
2-HYDROXY-5-(1-HYDROXY-2-[(1-METHYL-3-PHENYLPROPYL)AMINO]ETHYL)BENZAMIDE |
TRANDATEREG |
NORMODYNEREG |
SCH 15719W |
2-HYDROXY-5-(1-HYDROXY-2-((4-PHENYLBUTAN-2-YL)AMINO)ETHYL)BENZAMIDE |
178100706 |
D[VAL4,DARG8]VP |
178103782 |
7207 |
FDA Approval | 1984 |
Drug Class | small molecule |
Drug Indications | Antihypertensive Agents |
Year of Approval | 1984 |
Drug Class | antihypertensive agents |
agonist |
Specific Action of the Ligand | Full agonist |
Endogenous Drug? | False |
Direct Interaction? | False |
antagonist |
Trial Name | - |
Novel drug target | Established target |
Specific Action of the Ligand | Antagonist |
n/a |
Trial Name | - |
Novel drug target | Established target |
n/a |
Trial Name | - |
Novel drug target | Established target |
n/a |
Trial Name | - |
Novel drug target | Established target |
n/a |
n/a |
LABETALOL | Primary Drug Name |
Drug Class | antihypertensive agents |
Year of Approval | 1984 |
Drug Indications | Antihypertensive Agents |
Drug Class | small molecule |
FDA Approval | 1984 |
C29146 | NCI drug code |
LABETALOL | Primary Drug Name |
SPBIO_000905 | Drug Synonym |
LS-26936 | Drug Synonym |
LABETALOL | pubchem_primary_name |
3869 | PubChem CID |
LABETOLOL | Drug Synonym |
LABETALOL | GuideToPharmacology Ligand Name |
178103782 | PubChem Drug SID |
D[VAL4,DARG8]VP | GuideToPharmacology Ligand Name |
178100706 | PubChem Drug SID |